Latest Non Dilutive Funding News

Alicanto Minerals has obtained an A$18.1 million non-dilutive funding package from Stria Lithium, including cash and equity, to support resource expansion at the Mt Henry Gold Project, where diamond drilling is currently underway.

Latrobe Magnesium has locked in a US$2 million non-dilutive prepayment from its US distribution partner to accelerate commissioning of its Demonstration Plant, aiming for first magnesium deliveries in late 2026.

Right Resources Limited has secured over A$1.1 million in R&D-related funding, advancing its geological research and mineralisation modelling in NSW’s Tumbarumba district through a strategic partnership with the University of Tasmania’s CODES.

Nexsen Limited's subsidiary has won a HK$6 million grant to accelerate clinical validation and manufacturing of its rapid Group B Streptococcus diagnostic in Hong Kong, positioning the city as a key Asia-Pacific hub.

Bayan Mining and Minerals has secured membership in the U.S. Defense Industrial Base Consortium, opening doors to strategic partnerships and funding for its rare earth technologies, including a patented yttrium upgrade process. This move positions Bayan at the forefront of efforts to secure critical mineral supply chains vital to U.S. national security.

Sparc Technologies has secured a $680,000 non-dilutive advance on its anticipated FY26 R&D tax refund, strengthening its cash flow as it accelerates commercialisation of its graphene additive ecosparc and green hydrogen ventures.

Pioneer Minerals has secured membership in the US Defense Industrial Base Consortium, positioning its Idaho-based North Pine tungsten project at the heart of critical mineral supply chain initiatives.

Everest Metals Corporation reports outstanding high-grade gold intersections from its latest drilling at Mt Dimer Taipan, underpinning imminent mining and processing milestones. The project is fully funded and on track for near-term cash flow.

Albright Metals has completed the sale of part of its Bryah Basin tenements to Catalyst Metals, securing $1 million in cash and shares to advance its Golden Pike gold and antimony project in Canada.

BluGlass Limited reported a 14% revenue increase to A$5.76 million and a 28% reduction in net loss to A$4.1 million for H1 FY26, bolstered by a key US Department of War contract extension and a refreshed board driving growth.

Bioxyne Limited has reported a remarkable half-year performance, with revenues soaring 149% to $31.3 million and net profit more than doubling to $7.3 million, driven by strong demand for medicinal cannabis, MDMA, and psilocybin products and expanding international operations.

Lumos Diagnostics has hit a key enrollment milestone in its BARDA-funded paediatric study for FebriDx®, unlocking a US$720,000 payment and edging closer to FDA expansion.